Cancer cachexia update in head and neck cancer: Pathophysiology and treatment
- 14 March 2014
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 37 (7) , 1057-1072
Abstract
The pathophysiology of cancer cachexia remains complex. A comprehensive literature search was performed up to April 2013 using PubMed, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, and the Google search engine. In this review, we focus on the different mediators of impaired anabolism and upregulated catabolism that alter the skeletal muscle homeostasis resulting in the wasting of cancer cachexia. We present recent evidence of targeted treatment modalities from clinical trials along with their potential mechanisms of action. We also report on the most current evidence from randomized clinical trials using multimodal treatments in patients with cancer cachexia, but also the evidence from head and neck cancer‐specific trials. A more complete understanding of the pathophysiology of the syndrome may lead to more effective targeted therapies and improved outcomes for patients. © 2015 Wiley Periodicals, Inc. Head Neck 37: 1057–1072, 2015Keywords
This publication has 241 references indexed in Scilit:
- Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2013
- Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced CancerJournal of Pain and Symptom Management, 2011
- The muscle fiber type–fiber size paradox: hypertrophy or oxidative metabolism?European Journal of Applied Physiology, 2010
- Autophagy in skeletal muscleFEBS Letters, 2010
- Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stressFree Radical Biology and Medicine, 2008
- An overview of the endocrinology of skeletal muscleTrends in Endocrinology & Metabolism, 2004
- Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patientsSupportive Care in Cancer, 1997
- Is there a role for melatonin in the treatment of neoplastic cachexia?European Journal of Cancer, 1996
- Effect of extended ibuprofen administration on the acute phase protein response in colorectal cancer patientsEuropean Journal of Surgical Oncology, 1995
- Insulin resistance in patients with colorectal cancerBritish Journal of Surgery, 1987